Clinical issues in the pediatric hypertrophic cardiomyopathies

Progress in Pediatric Cardiology

Volumn 25, Issue 1, 2008, Pages 27-29

  Colan, Steven D ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENOTYPE; HEART TRANSPLANTATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; NOMENCLATURE; PEDIATRICS; PHENOTYPE; PRIORITY JOURNAL;

EID: 40949123786     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ppedcard.2007.11.004     Document Type: Note

References (12)

1. Maron B.J., Towbin J.A., Thiene G., et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113 (2006) 1807-1816
2. Colan S.D. Classification of the cardiomyopathies. Prog Pediatr Cardiol 23 (2007) 5-15
3. Colan S.D., Lipshultz S.E., Lowe A.M., et al. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry. Circulation 115 (2007) 773-781
4. Maron B.J., Chaitman B.R., Ackerman M.J., et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 109 (2004) 2807-2816
5. Taylor M.R., Carniel E., and Mestroni L. Familial hypertrophic cardiomyopathy: clinical features, molecular genetics and molecular genetic testing. Expert Rev Mol Diagn 4 (2004) 99-113
6. Van Driest S.L., Will M.L., Atkins D.L., and Ackerman M.J. A novel TPM1 mutation in a family with hypertrophic cardiomyopathy and sudden cardiac death in childhood. Am J Cardiol 90 (2002) 1123-1127
7. Richard P., Charron P., Carrier L., et al. Hypertrophic cardiomyopathy - distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107 (2003) 2227-2232
8. Maron B.J., Olivotto I., Spirito P., et al. Epidemiology of hypertrophic cardiomyopathy-related death - revisited in a large non-referral-based patient population. Circulation 102 (2000) 858-864
9. Van Driest S.L., Ommen S.R., Tajik A.J., Gersh B.J., and Ackerman M.J. Sarcomeric genotyping in hypertrophic cardiomyopathy. Mayo Clin Proc 80 (2005) 463-469
10. Ackerman M.J., Van Driest S.L., and Bos M. Are longitudinal, natural history studies the next step in genotype-phenotype translational genomics in hypertrophic cardiomyopathy?. J Am Coll Cardiol 46 (2005) 1744-1746
11. Lipshultz S.E., and Colan S.D. Cardiovascular trials in long-term survivors of childhood cancer. J Clin Oncol 22 (2004) 769-773
12. Silber J.H., Cnaan A., Clark B.J., et al. Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. J Clin Oncol 22 (2004) 820-828